Up
2004P-0074:
Oxandrolone and Widely used Anti-coagulant Durgs Containing the
Active Drug Warfarin
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
| CP1
|
| 02/17/2004
|
| 02/18/2004
|
| Drug Industry
|
| Savient Pharmaceuticalsl,
Inc.
|
|
|
|
|
|
|
| Petition
Tab
one, two,
three,
four, five, six
|
|
|
|
| Signature:
|
| Edward John Allera
|
|
|
| ACK1
|
| 02/18/2004
|
| 02/18/2004
|
| Federal Government
|
| HFA-305 to Savient
Pharmaceuticals, Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
| Signature:
|
| Lyle D. Jaffe
|
|
|
| C1
|
| 08/05/2004
|
| 08/04/2004
|
| Private Industry
|
| Heller Ehrman
|
|
|
|
|
|
|
| Comment
Tab
A, B, C
|
|
|
|
| Signature:
|
| James N. Czaban
|
|
|
| LET1
|
| 08/11/2004
|
| 08/11/2004
|
| Federal Government
|
| HFD-005 to Buchanan
Ingersoll, P.C.
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
| Signature:
|
| Jane A. Axelrad
|
|
|
|
| SUP1
|
| 09/17/2004
|
| 09/17/2004
|
| Private Industry
|
| Buchanan Ingersoll
|
|
|
|
|
|
|
| pdf
Attachment
one, two
|
|
|
|
| Signature:
|
| Edward John Allera
|
|
|
|
| C2
|
| 09/30/2004
|
| 09/28/2004
|
| Private Industry
|
| Hyman, Phelps &
McNamara PC
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Robert A Dormer, Josephine M
Torren
|
|
|
| C3
|
| 10/25/2004
|
| 10/22/2004
|
| Private Industry
|
| Heller Ehrman
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| James N. Czaban and Sanjay Sitlani
|
|
|
| SUP2
|
| 11/09/2004
|
| 11/09/2004
|
| Drug Industry
|
| Savient Pharmaceuticals
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Edward John Allerga
|
|
|
| C4
|
| 12/06/2004
|
| 12/06/2004
|
| Health Professional
|
| D. Flockhart, M.D.,
PhD
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| SUP3
|
| 02/25/2005
|
| 02/25/2005
|
| Drug Industry
|
| Savient Pharmaceuticalsl,
Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Edward John Allera
|
|
|
| C5
|
| 10/07/2005
|
| 10/07/2005
|
| Drug Industry
|
| Savient Pharmaceuticals,
Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Robert A. Dormer
|
|
|
| SUP4
|
| 02/02/2006
|
| 02/02/2006
|
| Drug Industry
|
| Savient Pharmaceuticals,
Inc. (Savient)
|
|
|
|
|
|
|
| pdf
Attachment
|
|
|
|
| Signature:
|
| Edward John Allera
|
|
|
| C6
|
| 02/27/2006
|
| 02/21/2006
|
| Private Industry
|
| Hyman, Phelps &
McNamara, P.C.
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Robert Robert A. Dormer and
Josephi
|
|
| |
| C7
|
| 03/17/2006
|
| 03/14/2006
|
| Individual Consumer
|
| D. Lowe
|
|
|
|
|
|
|
|
|
|
|
|
Top | Up
Page last updated
May 3, 2006
kk![horizonal rule](https://webarchive.library.unt.edu/eot2008/20081025065107im_/http://www.fda.gov/graphics/blkpixel.gif)
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |